Summary of antimicrobial prescribing guidance - managing common infections

Version 1.2, January 2024

UKHSA, NICE and other collaborators are discussing options for continued production of the Summary of Antimicrobial Prescribing Guidance (previously hosted by BNF Publications). In the interim we have produced a list of the conditions in the table linked to available national guidance.

We and have also included a condensed version of the table summary that includes infections covered by NICE antimicrobial prescribing guidance.

Fluoroquinolone antibiotics: In January 2024, the MHRA published a Drug Safety Update on fluoroquinolone antibiotics. These must now only be prescribed when other commonly recommended antibiotics are inappropriate. Stakeholders are assessing the impact of this warning on recommendations in the relevant guidance.

Please contact the TARGET team at for additional information if required.